Literature DB >> 32366511

Developing a vaccine for covid-19.

Sarah Caddy1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32366511     DOI： 10.1136/bmj.m1790

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  16 in total

1.  Tracking the progress in COVID-19 and vaccine safety research - a comprehensive bibliometric analysis of publications indexed in Scopus database.

Authors:  Tosin Yinka Akintunde; Shaojun Chen; Taha Hussein Musa; Felix Oluseyi Amoo; Adekunle Adedeji; Elhakim Ibrahim; Angwi Enow Tassang; Idriss Hussein Musa; Hassan Hussein Musa
Journal:  Hum Vaccin Immunother       Date:  2021-10-06       Impact factor: 4.526

Review 2.  SARS-CoV-2 vaccine candidates in rapid development.

Authors:  Lifeng Li; Pengbo Guo; Xiaoman Zhang; Zhidan Yu; Wancun Zhang; Huiqing Sun
Journal:  Hum Vaccin Immunother       Date:  2020-10-29       Impact factor: 3.452

3.  Effectiveness of Booster Measles-Mumps-Rubella Vaccination in Lower COVID-19 Infection Rates: A Retrospective Cohort Study in Turkish Adults.

Authors:  Erhan Yengil; Yusuf Onlen; Cahit Ozer; Mustafa Hambolat; Mehmet Ozdogan
Journal:  Int J Gen Med       Date:  2021-05-07

Review 4.  The Role of Lipid Metabolism in COVID-19 Virus Infection and as a Drug Target.

Authors:  Mohamed Abu-Farha; Thangavel Alphonse Thanaraj; Mohammad G Qaddoumi; Anwar Hashem; Jehad Abubaker; Fahd Al-Mulla
Journal:  Int J Mol Sci       Date:  2020-05-17       Impact factor: 5.923

5.  COVID-19 vaccination challenge: history lessons from a dermatologist's perspective.

Authors:  Diego Fernandez-Nieto; Daniel Ortega-Quijano; Juan Jimenez-Cauhe; Patricia Burgos-Blasco; Sonia Bea-Ardebol
Journal:  Int J Dermatol       Date:  2021-03-04       Impact factor: 3.204

Review 6.  Review of Covid-19 vaccine clinical trials - A puzzle with missing pieces.

Authors:  Hang Fai Kwok
Journal:  Int J Biol Sci       Date:  2021-04-10       Impact factor: 6.580

7.  The Impact of the COVID-19 "Infodemic" on Drug-Utilization Behaviors: Implications for Pharmacovigilance.

Authors:  Marco Tuccori; Irma Convertino; Sara Ferraro; Emiliano Cappello; Giulia Valdiserra; Daniele Focosi; Corrado Blandizzi
Journal:  Drug Saf       Date:  2020-08       Impact factor: 5.228

8.  Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial.

Authors:  Feng-Cai Zhu; Xu-Hua Guan; Yu-Hua Li; Jian-Ying Huang; Tao Jiang; Li-Hua Hou; Jing-Xin Li; Bei-Fang Yang; Ling Wang; Wen-Juan Wang; Shi-Po Wu; Zhao Wang; Xiao-Hong Wu; Jun-Jie Xu; Zhe Zhang; Si-Yue Jia; Bu-Sen Wang; Yi Hu; Jing-Jing Liu; Jun Zhang; Xiao-Ai Qian; Qiong Li; Hong-Xing Pan; Hu-Dachuan Jiang; Peng Deng; Jin-Bo Gou; Xue-Wen Wang; Xing-Huan Wang; Wei Chen
Journal:  Lancet       Date:  2020-07-20       Impact factor: 202.731

9.  Super-Spreaders or Victims of Circumstance? Childhood in Canadian Media Reporting of the COVID-19 Pandemic: A Critical Content Analysis.

Authors:  Sarah Ciotti; Shannon A Moore; Maureen Connolly; Trent Newmeyer
Journal:  Healthcare (Basel)       Date:  2022-01-14

10.  Willingness to vaccinate against Covid-19: A qualitative study involving older adults from Southern Switzerland.

Authors:  Marta Fadda; L Suzanne Suggs; Emiliano Albanese
Journal:  Vaccine X       Date:  2021-07-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.